SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Beckett, S.
Right arrow Articles by Marsden, C.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckett, S.
Right arrow Articles by Marsden, C.A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour

S. Beckett

Department of Physiology and Pharmacology, University Medical School Nottingham, Queen's Medical Centre, Nottingham NG71JG, UK

C.A. Marsden

Department of Physiology and Pharmacology, University Medical School Nottingham, Queen's Medical Centre, Nottingham NG71JG, UK

The effects of the selective 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OHDPAT) and the selective 5-HT1A antagonist, N-[2-[4-(2-methoxyphenyl)-1-piperzinyl]ethyl]-N-(pyridinyl) cyclohexanecarboxa mide trichloride (WAY100635) on periaqueductal grey (PAG)-stimulated defence behaviour were tested in the rat. Microinjection of the excitatory amino acid, D, L-homocysteic acid (DLH) into the dorsal region of the PAG produced overt aversive behaviour characteristic of the defence response, consisting of explosive motor behaviours which were quantified in terms of their duration and the number of arena revolutions and jumps made by the animal. Intra-PAG pre-treatment with 8-OHDPAT (3, 10 and 25 nmol in 250 nl) 10 min before DLH stimulation significantly attenuated the defence behaviour. This could be reversed by peripheral application of WAY100635 (0.1 mg/kg). In contrast, peripheral 8-OHDPAT (0.03, 0.1 and 0.3 mg/kg) produced a significant potentiation of the DLH response which could also be blocked by peripheral WAY100635. When WAY100635 (10 nmol in 250 nl) alone was given into the PAG a significant increase in DLH induced behaviours was observed whereas peripherally applied WAY100635 (0.1 mg/kg) was without effect. These data support previous findings which indicate that serotonergic modulation of aversive behaviours such as defence can be mediated by 5-HT 1A receptors. Furthermore there is evidence to indicate a differential involvement of pre- and post synaptic 5-HT1A receptors.

Key Words: 5-HT1A • 8-OHDPAT • aversion • defence response • periaqueductal grey • WAY100635

Journal of Psychopharmacology, Vol. 11, No. 1, 35-40 (1997)
DOI: 10.1177/026988119701100111


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
P. Johnson, C. Lowry, W. Truitt, and A. Shekhar
Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic
J Psychopharmacol, August 1, 2008; 22(6): 642 - 652.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
S.J. Davies, C.A. Lowry, and D.J. Nutt
Panic and hypertension: brothers in arms through 5-HT?
J Psychopharmacol, August 1, 2007; 21(6): 563 - 566.
[PDF]


Home page
J PsychopharmacolHome page
P. L. Johnson, J. H. Hollis, R. Moratalla, S. L. Lightman, and C. A. Lowry
Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats
J Psychopharmacol, July 1, 2005; 19(4): 327 - 341.
[Abstract] [PDF]



Advertisement